Sumitomo Chemical India Limited carries a market capitalization of 236.27B, placing it among publicly traded companies globally. Its enterprise value stands at 264.28B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 236.27B |
| Enterprise Value | 264.28B |
Sumitomo Chemical India Limited trades at a trailing price-to-earnings ratio of 47.43.
| PE Ratio | 47.43 |
| PS Ratio | 7.85 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Sumitomo Chemical India Limited trades at an EV/EBITDA multiple of 42.40 and an EV/FCF ratio of 5,611.39. The EV/Sales ratio of 7.85 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 42.40 provides insight into valuation relative to core operating earnings.
| EV / Sales | 7.85 |
| EV / EBITDA | 42.40 |
| EV / EBIT | 42.40 |
| EV / FCF | 5,611.39 |
Sumitomo Chemical India Limited maintains a current ratio of 6.11, meaning it holds 6.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.85, indicating elevated leverage, while an interest coverage ratio of 98.46 demonstrates strong ability to service its debt obligations.
| Current Ratio | 6.11 |
| Quick Ratio | 2.57 |
| Debt / Equity | 2.85 |
| Debt / EBITDA | N/A |
| Interest Coverage | 98.46 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 151.63 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Sumitomo Chemical India Limited has paid 1.92B in income taxes, reflecting an effective tax rate of 25.60.
| Income Tax | 1.92B |
| Effective Tax Rate | 25.60 |
Sumitomo Chemical India Limited's stock has declined approximately -5.67899% over the past 52 weeks. The 50-day moving average sits at 437.99, while the 200-day moving average is 467.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | -5.67899% |
| 50-Day Moving Average | 437.99 |
| 200-Day Moving Average | 467.73 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Sumitomo Chemical India Limited generated 33.66B in revenue and converted that into 5.57B in net income, yielding earnings per share of 11.18. EBITDA reached 6.23B, while operating income came in at 6.23B.
| Revenue | 33.66B |
| Gross Profit | 13.66B |
| Operating Income | 6.23B |
| Pretax Income | 7.50B |
| Net Income | 5.57B |
| EBITDA | 6.23B |
| EBIT | 6.23B |
| Earnings Per Share (EPS) | 11.18 |
Sumitomo Chemical India Limited operates with a gross margin of 40.56, reflecting its pricing power and cost economics. The operating margin of 18.51 and net profit margin of 16.55 provide insight into operational efficiency.
| Gross Margin | 40.56 |
| Operating Margin | 18.51 |
| Pretax Margin | 22.27 |
| Profit Margin | 16.55 |
| EBITDA Margin | 18.51 |
Sumitomo Chemical India Limited posts an Altman Z-Score of 34.60, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 34.60 |